payday loans
payday loans
Skip to content

Accueil FMC Bibliographie
Listing des derniers articles parus

Dans cette rubrique on vous propose une revue de la littérature à travers une sélection d'abstracts d'articles originaux.
On essaiera de vous tenir informé des dernières nouveautés de recherche en matière de Pneumologie. On ne vous fournit que le résumé de l'article et le lien correspondant, pour accéder à l'article en full text vous devez être inscrits à la revue correspondante.
Cliquez ici pour consulter la liste des revues de Pneumologie disponibles en libre accès.

Filtrer par titres     Affichage # 
# Titre de l'article
301 Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008
302 Advancements in Devices and Particle Engineering in Dry Powder Inhalation Technology.
303 Faster for less: the new "shorter" regimen for multidrug-resistant tuberculosis
304 Advances in pulmonary therapy and drug development: Lung tissue engineering to lung-on-a-chip.
305 Efficacy of recombinant human soluble thrombomodulin for the treatment of acute exacerbation of idiopathic pulmonary fibrosis: a single arm, non-randomized prospective clinical trial
306 Detection of Epstein-Barr Virus DNA in Langerhans Cell Histiocytosis.
307 Cost comparison of asthma treatments in 12-week study: caution about matching and short observational follow-up
308 Targeting MicroRNA Function in Respiratory Diseases: Mini-Review.
309 The effect of positive airway pressure therapy on neurocognitive functions, depression and anxiety in obesity hypoventilation syndrome
310 Allergen immunotherapy for allergic asthma: protocol for a systematic review.
311 European policies in the management of tuberculosis among migrants.
312 Guidelines or guidance for better idiopathic pulmonary fibrosis management?
313 Glucocorticoids may compromise the effect of gefitinib in non-small cell lung cancer.
314 Idiopathic pulmonary fibrosis - clinical management guided by the evidence-based GRADE approach: what arguments can be made against transparency in guideline development?
315 The Danish National Database for Asthma: establishing clinical quality indicators.
316 "Any fool can make a rule and any fool will mind it".
317 Mapping genetic research in non-communicable disease publications in selected Arab countries: first step towards a guided research agenda.
318 Pulmonary health effects of agriculture
319 Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring.
320 An update on pharmacologic management of chronic obstructive pulmonary disease
321 Regeneration of the Aging Lung: A Mini-Review.
322 Quality of life changes over time in patients with chronic obstructive pulmonary disease
323 Excess medical costs in patients with asthma and the role of comorbidity.
324 Long-term noninvasive ventilation in patients with chronic hypercapnic respiratory failure: assisting the diaphragm, but threatening the heart?
325 Clinical Characterization and Treatment Patterns for the Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease with Severe or Very Severe Airflow Limitation.
326 Lung volume reduction of pulmonary emphysema: the radiologist task
327 Stem/progenitor cells and obstructive sleep apnea syndrome - new insights for clinical applications.
328 Biomass smoke exposure and chronic lung disease
329 Classifying new anti-TB drugs: rationale and future perspectives.
330 Disease phenotyping in chronic obstructive pulmonary disease: the neutrophilic endotype
331 Carboplatin-induced hematotoxicity among patients with non-small cell lung cancer: Analysis on clinical adverse events and drug-gene interactions.
332 Pulmonary health effects of air pollution
333 End-of-life prognostic indicators in patients with COPD
334 Understanding the pathophysiology of the asthma–chronic obstructive pulmonary disease overlap syndrome
335 Risk factors for pulmonary arterial hypertension in children and young adults.
336 The Internet Of Medical Things: Digitization Revolutionizes Respiratory Care Management
337 New evidence of increased risk of rhinitis in subjects with COPD: a longitudinal population study.
338 Correlation between heart rate variability and pulmonary function adjusted by confounding factors in healthy adults.
339 Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis: methodological concerns.
340 Rationale for and design of the Idiopathic Pulmonary Fibrosis-PRospective Outcomes (IPF-PRO) registry.
341 Polymer-based novel lung targeted delivery systems.
342 New oncogenes drivers in lung cancer—new therapeutic targets
343 Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study.
344 Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis
345 Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008.
346 Tools of the Trade: Point-of-Care Ultrasonography as a Stethoscope
347 Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
348 N-acetylcysteine in COPD: why, how, and when?
349 The role of endobronchial ultrasonography for mediastinal lymphadenopathy in cases with extrathoracic malignancy.
350 [Non-invasive and invasive out of hospital ventilation in chronic respiratory failure : Consensus report of the working group on ventilation and intensive care medicine of the Austrian Society of Pneumology].
<< Début < Précédent 1 2 3 4 5 6 7 8 9 10 Suivant > Fin >>
Page 7 sur 198






PubMed Logo


Langtolang Dictionary



Notre site est optimisé pour les Navigateurs suivants : Firefox, Safari et Google Chrome. Cliquez sur l'un des logos ci-dessus pour le télécharger et l'installer gratuitement.


Accueil FMC Bibliographie Top